Nature Publishing Group

SHERPA: Unknown

People

  1. Brogi
    Brogi
  2. Pareja Zea
    Pareja Zea
  3. Weigelt
    Weigelt
  4. Selenica
    Selenica
  5. Wen
    Wen
  6. Norton
    Norton
  7. Robson
    Robson
  8. Chandarlapaty
    Chandarlapaty
  9. Zhang
    Zhang
  10. Berger
    Berger

Groups

  1. Department of Pathology and Laboratory Medicine (31)
  2. GSK Faculty (24)
  3. Department of Medicine (16)
  4. Sloan Kettering Institute Postdocs (16)
  5. Solid Tumor Oncology Division (16)
  6. Breast Medicine Service (15)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)
  8. GDMT, Pathology and Laboratory Medicine (11)
  9. Gynecology Disease Management Team (11)
  10. Human Oncology and Pathogenesis Program (9)
Search Within
  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (29)
  2. Review (2)
Groups
  1. Department of Pathology and Laboratory Medicine (31)
  2. GSK Faculty (24)
  3. Department of Medicine (16)
  4. Sloan Kettering Institute Postdocs (16)
  5. Solid Tumor Oncology Division (16)
  6. Breast Medicine Service (15)

More Groups

People
  1. Jorge Reis-Filho (19)
  2. Britta Weigelt (11)
  3. Edi Brogi (11)
  4. Fresia Pareja Zea (11)
  5. Pier Selenica (10)
  6. Hannah Wen (9)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (10)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. npj Breast Cancer (28)
  2. Nature Metabolism (1)
  3. Nature Structural and Molecular Biology (1)
  4. npj Genomic Medicine (1)

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biological correlates associated with high-risk breast cancer patients identified using a computational method
    Journal Article

    Oh, J. H.; Pareja, F.; Elkin, R.; Xu, K.; Norton, L.; Deasy, J. O.
    npj Breast Cancer (2025)

    Fulltext@MSK | Save
  • Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: A matched case analysis
    Journal Article

    Moss, N. S.; Singh, J. M.; Reiner, A. S.; Drago, J. Z.; Modi, S.; Seidman, A. D.; Chandarlapaty, S.; Ross, D. S.
    npj Breast Cancer (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: Is it a distinct entity?
    Journal Article

    Yu, J.; da Silva, E. M.; La, H. S.; Clark, B. Z.; Fine, J. L.; Carter, G. J.; Villatoro, T. M.; Soong, T. R.; Lee, A. V.; Oesterreich, S.; more...
    npj Breast Cancer (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
    Journal Article

    Barrios, C. H.; Saji, S.; Harbeck, N.; Zhang, H.; Jung, K. H.; Patel, S.; Patel, S.; Duc, A. N.; Liste-Hermoso, M.; Chui, S. Y.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • ERĪ±-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
    Journal Article

    Strillacci, A.; Sansone, P.; Rajasekhar, V. K.; Turkekul, M.; Boyko, V.; Meng, F.; Houck-Loomis, B.; Brown, D.; Berger, M. F.; Hendrickson, R. C.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy
    Journal Article

    Grabenstetter, A.; Brogi, E.; Zhang, H.; Razavi, P.; Reis-Filho, J. S.; VanZee, K. J.; Norton, L.; Wen, H. Y.
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors
    Journal Article

    Elkin, R.; Oh, J. H.; Liu, Y. L.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Zamarin, D.; Deasy, J. O.; Norton, L.; Levine, A. J.; more...
    npj Genomic Medicine (2021)

    Fulltext@MSK | Save
  • The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
    Review

    El Bairi, K.; Haynes, H. R.; Blackley, E.; Fineberg, S.; Shear, J.; Turner, S.; de Freitas, J. R.; Sur, D.; Amendola, L. C.; Gharib, M.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination
    Journal Article

    Setton, J.; Selenica, P.; Mukherjee, S.; Shah, R.; Pecorari, I.; McMillan, B.; Pei, I. X.; Kemel, Y.; Ceyhan-Birsoy, O.; Sheehan, M.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save

    • Nature Publishing Group – authorized name for: